Featured
Moderate Sleep Linked to Slower Biological Aging
Clinic Moves Oct 1, 2026
Trial Briefs Sep 30, 2026
Clinic Moves Sep 29, 2026
A study in Nature overturns the assumption that longer sleep is universally better for aging....
Hypertension cases in England reveal 37.2% prevalence, with 58.8% undetected per 1.4 million adult study,...
Support brain health naturally with new habits like crocheting and exercise, one of the best...
Read our latest Drug Approvals articles.
Doctors reject federal vaccine changes lacking scientific backing as top medical groups like AAP and...
Vonoprazan significantly reduces nighttime reflux symptoms in patients with NERD, offering a promising new treatment...
GammaTile slows brain tumor regrowth in glioblastoma patients with promising results from the GESTALT trial...
A study in Nature overturns the assumption that longer sleep is universally better for aging. The research instead shows that both insufficient and.
A study in Nature overturns the assumption that longer sleep is universally better for aging. The research instead shows that...
Magnesium deficiency affects 70% of Americans, yet standard tests miss it. Learn why 99% is stored in bones and how...
Hypertension cases in England reveal 37.2% prevalence, with 58.8% undetected per 1.4 million adult study, exposing major screening gaps.
Support brain health naturally with new habits like crocheting and exercise, one of the best ways to improve overall health.
Kohler Wisconsin redefines wellness retreats with integrated design, blending movement, recovery, and architecture into a cohesive experience.
Standard physical tests often fail to diagnose chronic pelvic pain effectively. Learn how brain processing and inflammation play a larger...
Scientists suggest boosting glutathione may slow age-related cellular decline, offering one of the most promising approaches to support long-term health.
Family physicians weigh multiple factors when deciding whether to refer a patient for a hearing assessment, including symptoms and access...
Tirzepatide and semaglutide have similar asthma risks in adults with type 2 diabetes and asthma.
FDA reviews two novel ADHD drug candidates in late-stage development, offering new approaches to treatment.